{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:16:05Z","timestamp":1793643365638,"version":"4.5.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DA053372"],"award-info":[{"award-number":["1R01DA053372"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P30NS047101"],"award-info":[{"award-number":["P30NS047101"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neuropharm.2023.109683","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T06:09:00Z","timestamp":1691042940000},"page":"109683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Buprenorphine and methadone differentially alter early brain development in human cortical organoids"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7700-7161","authenticated-orcid":false,"given":"Hang","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2379-6798","authenticated-orcid":false,"given":"Daisy","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen H.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6964-6684","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel G.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109683_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroscience.2007.05.053","article-title":"Caspase-3 activity is reduced after spinal cord injury in mice lacking dynorphin: differential effects on glia and neurons","volume":"148","author":"Adjan","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109683_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuron.2018.10.007","article-title":"Building models of brain disorders with three-dimensional organoids","volume":"100","author":"Amin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109683_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2020.104997","article-title":"Prenatal exposure to methadone or buprenorphine and long-term outcomes: a meta-analysis","volume":"143","author":"Andersen","year":"2020","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.neuropharm.2023.109683_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrneurol.2017.45","article-title":"Human induced pluripotent stem cells for modelling neurodevelopmental disorders","volume":"13","author":"Ardhanareeswaran","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10550881003684871","article-title":"Prenatal drug exposure: infant and toddler outcomes","volume":"29","author":"Bandstra","year":"2010","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.neuropharm.2023.109683_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/clpt.1988.86","article-title":"The use of serum methadone levels in patients receiving methadone maintenance","volume":"43","author":"Bell","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2023.109683_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0002-9378(75)90461-5","article-title":"Methadone assays in pregnant women and progeny","volume":"121","author":"Blinick","year":"1975","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1213\/01.ANE.0000099723.75548.DF","article-title":"Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects","volume":"98","author":"Callahan","year":"2004","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2023.109683_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/adar.2021.10009","article-title":"Mechanisms underlying the anti-suicidal treatment potential of buprenorphine","volume":"1","author":"Cameron","year":"2021","journal-title":"Adv. Drug. Alcohol. Res."},{"key":"10.1016\/j.neuropharm.2023.109683_bib10","doi-asserted-by":"crossref","first-page":"139 e131","DOI":"10.1016\/j.ajog.2010.10.004","article-title":"Methadone and perinatal outcomes: a retrospective cohort study","volume":"204","author":"Cleary","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2023.109683_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1360-0443.2012.04040.x","article-title":"Neonatal neurobehavior effects following buprenorphine versus methadone exposure","volume":"107","author":"Coyle","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2023.109683_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrn.2017.107","article-title":"The use of brain organoids to investigate neural development and disease","volume":"18","author":"Di Lullo","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41398-023-02397-3","article-title":"Methadone alters transcriptional programs associated with synapse formation in human cortical organoids","volume":"13","author":"Dwivedi","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109683_bib14","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The role of opioid receptors in immune system function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/scd.2022.0116","article-title":"Cerebral organoids to study central mechanisms of pain: the effect of stem cell secretome on opioid receptors and neuroplasticity","volume":"31","author":"Fernandes","year":"2022","journal-title":"Stem Cell. Dev."},{"key":"10.1016\/j.neuropharm.2023.109683_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13477","article-title":"A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder","volume":"147","author":"Gottlieb","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2023.109683_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66230","article-title":"Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry","volume":"10","author":"Grecco","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2023.109683_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1460-9568.2000.01015.x","article-title":"Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation","volume":"12","author":"Hauser","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib19","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/jn.2001.85.3.1153","article-title":"Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell","volume":"85","author":"Hjelmstad","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib20","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1152\/jn.01115.2002","article-title":"Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms","volume":"89","author":"Hjelmstad","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03639045.2019.1706552","article-title":"Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data","volume":"46","author":"Hjelmstrom","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.neuropharm.2023.109683_bib22","first-page":"1","article-title":"Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder","author":"Ho","year":"2022","journal-title":"Mol. Psychiatr.28"},{"key":"10.1016\/j.neuropharm.2023.109683_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12964-022-00833-3","article-title":"Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway","volume":"20","author":"Huang","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuropharm.2023.109683_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00194-0","article-title":"Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes","volume":"63","author":"Johnson","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109683_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1542\/peds.58.5.681","article-title":"Differential effects of maternal heroin and methadone use on birthweight","volume":"58","author":"Kandall","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2023.109683_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1475-2867-13-93","article-title":"Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells","volume":"13","author":"Kharmate","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.neuropharm.2023.109683_bib27","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/10826084.2022.2083174","article-title":"Buprenorphine compared with methadone in pregnancy: a systematic review and meta-analysis","volume":"57","author":"Kinsella","year":"2022","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.neuropharm.2023.109683_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108008","article-title":"Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats","volume":"212","author":"Kongstorp","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109683_bib29","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/0024-3205(94)00937-6","article-title":"The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine","volume":"56","author":"Kristensen","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/bjc.2011.574","article-title":"Effect of kappa-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells","volume":"106","author":"Kuzumaki","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuropharm.2023.109683_bib31","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1523\/JNEUROSCI.1371-20.2021","article-title":"Effects of altered excitation-inhibition balance on decision making in a cortical circuit model","volume":"42","author":"Lam","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0014-2999(88)90543-2","article-title":"Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice","volume":"151","author":"Leander","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e3182557917","article-title":"Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial mu-opioid receptor agonist buprenorphine","volume":"116","author":"Leffler","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2023.109683_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.stem.2016.07.017","article-title":"Neural differentiation in the third dimension: generating a human midbrain","volume":"19","author":"Marton","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2023.109683_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2018.01.040","article-title":"Six-month cultured cerebral organoids from human ES cells contain matured neural cells","volume":"670","author":"Matsui","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109683_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.earlhumdev.2014.10.006","article-title":"Infants of opioid-dependent mothers: neurodevelopment at six months","volume":"91","author":"McGlone","year":"2015","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.neuropharm.2023.109683_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nicl.2017.12.033","article-title":"Prenatal methadone exposure is associated with altered neonatal brain development","volume":"18","author":"Monnelly","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neuropharm.2023.109683_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.889922","article-title":"Buprenorphine exposure alters the development and migration of interneurons in the cortex","volume":"15","author":"Nieto-Estevez","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.3415","article-title":"Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture","volume":"12","author":"Pasca","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2023.109683_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20675","article-title":"Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain","volume":"56","author":"Sanchez","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2023.109683_bib43","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1055\/s-0040-1721693","article-title":"Is maternal methadone dose associated with the severity of neonatal abstinence syndrome?","volume":"39","author":"Smith","year":"2022","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib44","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2023.109683_bib45","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0541","article-title":"Neonatal head circumference in newborns with neonatal abstinence syndrome","volume":"143","author":"Towers","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2023.109683_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.stem.2019.08.002","article-title":"Complex oscillatory waves emerging from cortical organoids model early human brain network development","volume":"25","author":"Trujillo","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2023.109683_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000365074","article-title":"The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination","volume":"36","author":"Vestal-Laborde","year":"2014","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114014","article-title":"Toosendanin-induced apoptosis in colorectal cancer cells is associated with the kappa-opioid receptor\/beta-catenin signaling axis","volume":"177","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.593248","article-title":"Methadone suppresses neuronal function and maturation in human cortical organoids","volume":"14","author":"Wu","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109683_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102065","article-title":"Methadone interrupts neural growth and function in human cortical organoids","volume":"49","author":"Yao","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.neuropharm.2023.109683_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2006.02.001","article-title":"Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD\/P53 and anti-apoptotic PI3K\/Akt\/NF-kappaB pathways","volume":"174","author":"Yin","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2023.109683_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41592-018-0255-0","article-title":"Reliability of human cortical organoid generation","volume":"16","author":"Yoon","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2023.109683_bib53","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:24:58Z","timestamp":1758439498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":53,"alternative-id":["S0028390823002733"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109683","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine and methadone differentially alter early brain development in human cortical organoids","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109683"}}